Evaluation of the new anti-inflammatory compound ethyl salicylate 2-O-β-d-glucoside and its possible mechanism of action
Wenyu Xin(Binzhou Medical University), Guanhua Du(Shanghai Jiao Tong University), Chao Huang(Beijing Forestry University), Tiantai Zhang(Chinese Academy of Medical Sciences & Peking Union Medical College), Chao Wang(McLean Hospital), Xue Zhang(Shanghai University of Traditional Chinese Medicine), Xiaowei Ma(Shanghai Jiao Tong University), Dongming Zhang(Heilongjiang Bayi Agricultural University), Lan Sun(Affiliated Hospital of Shaanxi University of Chinese Medicine)
Cited by 20
Related Papers
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis
|Oncogene|2001|233
SIRT1 Acts as a Modulator of Neointima Formation Following Vascular Injury in Mice
|Circulation Research|2011|183
Molecular Design Strategy to Construct the Near-Infrared Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2J2
|Journal of the American Chemical Society|2018|164
The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro
|Biochemical Pharmacology|2020|160